Format

Send to

Choose Destination
Am J Cardiol. 2004 May 15;93(10):1320-2.

Effectiveness of sotalol treatment in symptomatic Brugada syndrome.

Author information

1
University of California-San Francisco, San Francisco, CA, USA. kaglatter@ucdavis.edu

Abstract

We describe a 53-year-old man with recurrent syncopal events and a malignant family history who was treated for 13 years with sotalol drug therapy with no further occurrence of Brugada syndrome symptoms. Genetic testing revealed that he carried a Brugada syndrome sodium channel SCN5A mutation (4189delT). This finding suggests that sotalol may be of therapeutic benefit in such patients.

PMID:
15135718
DOI:
10.1016/j.amjcard.2004.02.023
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center